Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,260 | 574 | 99.7% |
| Education | $31.05 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,378 | 93 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,331 | 82 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $889.38 | 48 | $0 (2023) |
| Amgen Inc. | $769.83 | 52 | $0 (2024) |
| Lilly USA, LLC | $728.33 | 46 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $554.95 | 33 | $0 (2024) |
| Amarin Pharma Inc. | $390.54 | 27 | $0 (2022) |
| PFIZER INC. | $383.86 | 25 | $0 (2024) |
| Novo Nordisk Inc | $367.88 | 30 | $0 (2024) |
| ABBVIE INC. | $247.86 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $692.77 | 38 | GlaxoSmithKline, LLC. ($150.71) |
| 2023 | $791.32 | 46 | GlaxoSmithKline, LLC. ($205.94) |
| 2022 | $1,221 | 70 | Lilly USA, LLC ($236.89) |
| 2021 | $1,017 | 67 | AbbVie Inc. ($152.12) |
| 2020 | $1,011 | 61 | AstraZeneca Pharmaceuticals LP ($208.41) |
| 2019 | $1,331 | 95 | AstraZeneca Pharmaceuticals LP ($213.22) |
| 2018 | $1,716 | 95 | AstraZeneca Pharmaceuticals LP ($347.43) |
| 2017 | $1,512 | 107 | AstraZeneca Pharmaceuticals LP ($206.64) |
All Payment Transactions
579 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: GI | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: HEMATOLOGY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Insomnia | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 700 | 1,881 | $213,899 | $97,894 |
| 2022 | 31 | 1,042 | 3,007 | $309,452 | $139,871 |
| 2021 | 30 | 1,529 | 3,606 | $436,277 | $196,850 |
| 2020 | 31 | 1,941 | 3,687 | $441,925 | $207,467 |
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 253 | $37,950 | $21,405 | 56.4% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2023 | 61 | 319 | $31,900 | $13,921 | 43.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 89 | $22,250 | $11,341 | 51.0% |
| 96521 | Refilling and maintenance of portable pump | Office | 2023 | 13 | 104 | $13,136 | $7,817 | 59.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 100 | $13,000 | $6,169 | 47.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 25 | 28 | $6,305 | $4,365 | 69.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 39 | 53 | $15,688 | $4,152 | 26.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 15 | 15 | $5,225 | $3,911 | 74.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 13 | 103 | $6,375 | $3,848 | 60.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 45 | 66 | $19,169 | $3,669 | 19.1% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 39 | 53 | $6,890 | $3,221 | 46.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 25 | 28 | $5,008 | $3,013 | 60.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $3,269 | $2,934 | 89.8% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 15 | 15 | $3,655 | $2,866 | 78.4% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 13 | 104 | $2,045 | $1,307 | 63.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 26 | 28 | $2,100 | $690.75 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 73 | $3,650 | $680.30 | 18.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 58 | $8,700 | $578.34 | 6.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 21 | 22 | $1,650 | $476.99 | 28.9% |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) | Office | 2023 | 11 | 13 | $975.00 | $366.08 | 37.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 22 | $928.84 | $356.84 | 38.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 24 | 119 | $1,785 | $334.54 | 18.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 35 | $269.50 | $264.25 | 98.1% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 15 | 15 | $1,250 | $130.60 | 10.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 64 | $320.00 | $47.88 | 15.0% |
About Dr. Patrick Moore, M.D
Dr. Patrick Moore, M.D is a Family Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982604419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Moore, M.D has received a total of $9,291 in payments from pharmaceutical and medical device companies, with $692.77 received in 2024. These payments were reported across 579 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($9,260).
As a Medicare-enrolled provider, Moore has provided services to 5,212 Medicare beneficiaries, totaling 12,181 services with total Medicare billing of $642,083. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lafayette, LA
- Active Since 07/27/2005
- Last Updated 10/05/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982604419
Products in Payments
- FARXIGA (Drug) $1,107
- TRELEGY ELLIPTA (Drug) $1,050
- JARDIANCE (Drug) $833.76
- ENTRESTO (Drug) $554.95
- Aimovig (Biological) $411.61
- Vascepa (Drug) $390.54
- TRULICITY (Drug) $363.88
- NEXLETOL (Drug) $238.21
- Otezla (Drug) $229.28
- BREO (Drug) $203.84
- Ozempic (Drug) $199.85
- MOUNJARO (Drug) $186.31
- XARELTO (Drug) $166.88
- JANUVIA (Drug) $165.81
- CHANTIX (Drug) $160.11
- Movantik (Drug) $133.09
- LODOCO (Drug) $128.99
- ANORO (Drug) $124.15
- Victoza (Drug) $122.67
- IN.PACT Admiral (Device) $121.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lafayette
Dr. Stephen Badylak, Dvm, Md, Phd, DVM, MD, PHD
Family Medicine — Payments: $1.8M
William Bray, M.d, M.D
Family Medicine — Payments: $167,020
Michael Iannotti, M.d, M.D
Family Medicine — Payments: $43,574
Dr. Matthew Abraham, M.d, M.D
Family Medicine — Payments: $23,305
Dr. Darrin Menard, Md, MD
Family Medicine — Payments: $15,683
Dr. Geoffrey Mire, Md, MD
Family Medicine — Payments: $15,244